What is the level of liabilities of NanoRepro this year?
NanoRepro has a debt balance of 2.04 M EUR this year.
NanoRepro Liabilities 2024
NanoRepro Liabilities
2.04 M EUR
NanoRepro Dividend yield
27.47 %
Ticker
NN6.DE
ISIN
DE0006577109
WKN
657710
In 2024, NanoRepro's total liabilities amounted to 2.04 M EUR, a -90.53% difference from the 21.54 M EUR total liabilities in the previous year.
NanoRepro Aktienanalyse
What does NanoRepro do?
The Nanorepro AG was founded in 1998 in Marburg an der Lahn and has since developed into a leading company in the development and production of diagnostic rapid tests and self-tests. The company has been listed on the Frankfurt Stock Exchange since 2006 and has its headquarters in the university city of Marburg. Nanorepro's business model focuses on the production and distribution of innovative, reliable, and easy-to-use self-tests for the medical field. The company concentrates on the practical application of the tests - they should be simple, fast, and user-friendly. Nanorepro's core competence lies in the design, production, and distribution of rapid tests and self-tests for the medical field. The company relies on close cooperation with other companies and research institutions to continuously improve the tests and develop new products. Nanorepro focuses on various areas, including the manufacturing of rapid tests and self-tests for the diagnosis of infectious diseases. In addition, the company also offers tests to check pregnancy status or determine ovulation. Nanorepro's range of products also includes self-tests for the early detection of diseases such as diabetes. With its wide range of products, the company is able to address a large customer base and achieve a positive market position. One key product of Nanorepro is the early pregnancy test. This product is easy to handle and allows women to quickly and safely determine if they are pregnant or not. Nanorepro also offers an ovulation test to help women determine the timing of ovulation. Another test offered by the company is the Lyme borreliosis self-test, which allows for the detection of antibodies to Lyme borreliosis. Nanorepro also offers numerous tests for diagnosing infectious diseases. These include tests that can diagnose bacterial or viral infections such as streptococcal infections or hepatitis B and C. The tests are highly accurate and reliable, enabling quick diagnosis and treatment. Another area in which Nanorepro is expanding is the development of self-tests for the early detection of cancer. For this purpose, the company works closely with scientific and research institutions to continuously improve the tests and make them even more precise and reliable. Nanorepro places a strong emphasis on quality control and safety in the production of the tests. The products are CE-certified, ensuring high quality and safety for the user. In addition, the company has been certified according to the standards of the International Quality Management System ISO 13485, guaranteeing a high standard in the production and marketing of medical devices. Overall, Nanorepro AG has established itself as a leading company in the field of rapid tests and self-tests. With its wide range of products and constant willingness to innovate, the company is able to quickly and effectively respond to the requirements of customers and partners. The company's extensive experience in the field of medical diagnostics contributes to Nanorepro being perceived as a reliable partner in medical technology. NanoRepro ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing NanoRepro's Liabilities
NanoRepro's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating NanoRepro's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing NanoRepro's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
NanoRepro's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in NanoRepro’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about NanoRepro Stock
What were the liabilities of NanoRepro compared to the previous year?
The liabilities of NanoRepro have increased by -90.53% dropped compared to the previous year.
What are the consequences of high debt for investors of NanoRepro?
High liabilities can pose a risk for investors of NanoRepro, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in NanoRepro?
Low liabilities mean that NanoRepro has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of NanoRepro affect the company?
An increase in liabilities of NanoRepro can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of NanoRepro affect the company?
A decrease in the liabilities of NanoRepro can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of NanoRepro?
Some factors that can influence the liabilities of NanoRepro include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of NanoRepro so important for investors?
The liabilities of NanoRepro are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can NanoRepro take to modify the liabilities?
To change its liabilities, NanoRepro can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does NanoRepro pay?
Over the past 12 months, NanoRepro paid a dividend of 0.5 EUR . This corresponds to a dividend yield of about 27.47 %. For the coming 12 months, NanoRepro is expected to pay a dividend of 0.5 EUR.
What is the dividend yield of NanoRepro?
The current dividend yield of NanoRepro is 27.47 %.
When does NanoRepro pay dividends?
NanoRepro pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of NanoRepro?
NanoRepro paid dividends every year for the past 1 years.
What is the dividend of NanoRepro?
For the upcoming 12 months, dividends amounting to 0.5 EUR are expected. This corresponds to a dividend yield of 27.47 %.
In which sector is NanoRepro located?
NanoRepro is assigned to the 'Health' sector.
Wann musste ich die Aktien von NanoRepro kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of NanoRepro from 6/20/2023 amounting to 0.15 EUR, you needed to have the stock in your portfolio before the ex-date on 6/16/2023.
When did NanoRepro pay the last dividend?
The last dividend was paid out on 6/20/2023.
What was the dividend of NanoRepro in the year 2023?
In the year 2023, NanoRepro distributed 0 EUR as dividends.
In which currency does NanoRepro pay out the dividend?
The dividends of NanoRepro are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The NanoRepro stock can be added to a savings plan with the following providers: ING
Andere Kennzahlen von NanoRepro
Our stock analysis for NanoRepro Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NanoRepro Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
